Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year

Reuters
2025/07/22
<a href="https://laohu8.com/S/HYEX">Healthy Extracts</a> Inc. Reports Record <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year

Healthy Extracts Inc. has announced preliminary unaudited results for the second quarter of 2025, with expectations of record sales and strong positive adjusted EBITDA at nearly $100,000. The company's growth has been driven by subscription-based recurring revenue, which saw a more than 107% increase from Amazon "Subscribe & Save" customers and an 88% increase in direct-to-consumer subscription customers. Healthy Extracts anticipates maintaining a robust performance with a projected net revenue growth of 34% for the full year 2025. The company has achieved record-setting revenue for three consecutive quarters, credited to effective growth strategies and expansion across direct-to-consumer and retail channels. Healthy Extracts has recently launched new product formulations, expanding into sleep and gut health categories. These new offerings, combined with strategic cross-promotion and a top three ranking on Amazon, fortify the company's market position. Looking ahead, Healthy Extracts plans to continue its growth trajectory by introducing additional products and categories in the third quarter, including a novel oral delivery system developed in partnership with Gelteq. The company aims to sustain its revenue and profitability growth through strategic reinvestment in product development and channel expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthy Extracts Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1051201) on July 22, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10